Direct Factor Xa Inhibitors - LabCE.com, Laboratory Continuing Education

How to Subscribe

MLS & MLT Comprehensive CE Package Includes 137 CE courses, most popular	$95	Add to cart
Pick Your Courses Up to 8 CE hours	$50	Add to cart
Individual course	$20	Add to cart

The page below is a sample from the LabCE course Antiplatelet and Anticoagulant Pharmacology for the Laboratory Professional. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Antiplatelet and Anticoagulant Pharmacology for the Laboratory Professional (online CE course)

Direct Factor Xa Inhibitors

Examples: This class of drugs includes rivaroxaban and apixaban. These drugs are administered orally.
Mechanism of action: These drugs bind to factor Xa, resulting in the direct inhibition of Xa. Once factor Xa is inhibited, it cannot function in the coagulation cascade and the fibrin clot cannot form.
Use: Direct Factor Xa Inhibitors are used in the chronic management of hypercoagulability.
Laboratory measurement: These drugs do not require routine laboratory monitoring. Please see the following link if you wish to obtain more in-depth knowledge on how these medications affect coagulation testing: http://emj.bmj.com/content/emermed/early/2015/05/17/emermed-2015-204891.full.pdf
Toxicity: All anticoagulants can cause excessive bleeding, but there is not a reversal agent for this class of medications. PCC does provide a partial reversal of these drugs, however.